in men and women, respectively), 6 though it should be noted that both cohorts were labeled high risk. The reported incidence of CEs in HIV-infected patients ranges from 3.5 to 11.1 per 1000 patient-years. 3 These variations are due to the different methods used in the various studies and the different types and end points considered. All these studies include mostly Anglo-Saxon patients, who usually have a greater incidence of CEs than Spanish people, as well as having a slightly older mean age. 3 Our study, despite the limitations associated with a cross-sectional design (no inclusion of patients who are lost or dead), approximates to the true situation in our area regarding the incidence of cardiovascular events and the type of patient affected in this population. Thus, the patients with CEs in our series were older and had a greater prevalence of certain traditional CVRF, such as hypertension or a family history of ischemic heart disease. No differences were seen in other traditional CVRF like smoking, which is probably due to the very high prevalence of smokers among the whole cohort, and dyslipidemia, which is also quite frequent in our patients.
Though the incidence of CEs in our study was slightly higher than that in the general Spanish population, the fact that it was a young cohort with a high prevalence of CVRF, some much more common than in the general population, suggests that in the coming years cardiovascular events, and particularly CEs, will become frequent in HIV-infected patients. Just as in the general population, prevention strategies should be designed and action should be taken on modifiable factors in order to stem, as far as possible, the foreseeable growth in cardiovascular diseases in HIV-infected patients. 
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